| Issue Date | Title | Author(s) | Source | scopus | WOS | Fulltext/Archive link |
| 2007 | Acquisition and cure of autoimmune disease following allogeneic hematopoietic stem cell transplantation | Hou H.-A.; Tang J.-L.; SZU-CHUN HSU ; Yu C.-L.; Chen Y.-C.; Yao M. | Journal of the Formosan Medical Association | | 4 | |
| 2009 | Acute myeloid leukemia bearing t(7;11)(p15;p15) is a distinct cytogenetic entity with poor outcome and a distinct mutation profile: Comparative analysis of 493 adult patients | Chou W.-C.; Chen C.-Y.; Hou H.-A.; Lin L.-I.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; SZU-CHUN HSU ; Chen Y.-C.; Huang Y.-N.; Tseng M.-H.; Huang C.-F.; Tien H.-F. | Leukemia | | 45 | |
| 2008 | Adrenal insufficiency in prolonged critical illness | Wu J.-Y.; SZU-CHUN HSU ; Ku S.-C.; Ho C.-C.; Yu C.-J.; Yang P.-C. | Critical Care | | 14 | |
| 2009 | AML1/RUNX1 mutations in 470 adult patients with de novo acute myeloid leukemia: Prognostic implication and interaction with other gene alterations | Tang J.-L.; Hou H.-A.; Chen C.-Y.; Liu C.-Y.; Chou W.-C.; Tseng M.-H.; Huang C.-F.; Lee F.-Y.; Liu M.-C.; Yao M.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU ; Wu S.-J.; Tsay W.; Chen Y.-C.; Lin L.-I.; Tien H.-F. | Blood | | 236 | |
| 2007 | Bifunctional magnetic silica nanoparticles for highly efficient human stem cell labeling | Lu C.-W.; Hung Y.; Hsiao J.-K.; Yao M.; Chung T.-H.; Lin Y.-S.; Wu S.-H.; SZU-CHUN HSU ; Liu H.-M.; Mou C.-Y.; Yang C.-S.; Huang D.-M.; Chen Y.-C. | Nano Letters | | 451 | |
| 2009 | Bone marrow angiogenesis magnetic resonance imaging in patients with acute myeloid leukemia: Peak enhancement ratio is an independent predictor for overall survival | Shih T.T.-F.; Hou H.-A.; Liu C.-Y.; Chen B.-B.; Tang J.-L.; Chen H.-Y.; Wei S.-Y.; Yao M.; Huang S.-Y.; Chou W.-C.; SZU-CHUN HSU ; Tsay W.; Yu C.-W.; Hsu C.-Y.; Tien H.-F.; Yang P.-C. | Blood | | 58 | |
| 2021 | Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients | Huang, Shang-Yi; Lin, Hsiu-Hsia; MING YAO; Tang, Jih-Luh; Wu, Shang-Ju; Chou, Wen-Chien; SZU-CHUN HSU ; Ko, Bor-Sheng; Tien, Hwei-Fang | Journal of the Formosan Medical Association = Taiwan yi zhi | 1 | 0 | |
| 2021 | Cd9 upregulation-decreased ccl21 secretion in mesenchymal stem cells reduces cancer cell migration | Hsieh C.-C.; SZU-CHUN HSU ; Yao M.; Huang D.-M. | International Journal of Molecular Sciences | | 3 | |
| 2009 | Chronic myeloid leukemia in Asia | Au W.Y.; Caguioa P.B.; Chuah C.; SZU-CHUN HSU ; Jootar S.; Kim D.-W.; Kweon I.-Y.; O'Neil W.M.; Saikia T.K.; Wang J. | International Journal of Hematology | | 74 | |
| 2015 | Clinical and prognostic implications of roundabout 4 (Robo4) in adult patients with acute myeloid leukemia | Chen Y.-K.; Hou H.-A.; Tang J.-L.; Jhuang J.-Y.; Lai Y.-J.; Lee M.-C.; Kuo Y.-Y.; Chou W.-C.; Liu C.-Y.; Lin C.-W.; Chuang S.-S.; Chen C.-Y.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Yao M.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU ; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. | PLoS ONE | | 3 | |
| 2018 | Clinically validated machine learning algorithm for detecting residual diseases with multicolor flow cytometry analysis in acute myeloid leukemia and myelodysplastic syndrome | Ko B.-S.; Wang Y.-F.; Li J.-L.; Li C.-C.; Weng P.-F.; SZU-CHUN HSU ; Hou H.-A.; Huang H.-H.; Yao M.; Lin C.-T.; Liu J.-H.; Tsai C.-H.; Huang T.-C.; Wu S.-J.; Huang S.-Y.; Chou W.-C.; Tien H.-F.; Lee C.-C.; Tang J.-L. | EBioMedicine | | 26 | |
| 2018 | Concomitant WT1 mutations predict poor prognosis in acute myeloid leukemia patients with double mutant CEBPA | Tien F.-M.; Hou H.-A.; Tang J.-L.; Kuo Y.-Y.; Chen C.-Y.; Tsai C.-H.; Yao M.; Lin C.-T.; Li C.-C.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU ; Wu S.-J.; Liu J.-H.; Chou S.-C.; Tsay W.; Tseng M.-H.; Liu M.-C.; Liu C.-W.; Lin L.-I.; Chou W.-C.; Tien H.-F. | Haematologica | | 14 | |
| 2012 | Correlation among DCE-MRI measurements of bone marrow angiogenesis, microvessel density, and extramedullary disease in patients with multiple myeloma | Huang S.-Y.; Chen B.-B.; Lu H.-Y.; Lin H.-H.; Wei S.-Y.; SZU-CHUN HSU ; Shih T.T.-F. | American Journal of Hematology | | 11 | |
| 2018 | Dextran-coated iron oxide nanoparticle-improved therapeutic effects of human mesenchymal stem cells in a mouse model of Parkinson's disease | Chung T.-H.; SZU-CHUN HSU ; Wu S.-H.; Hsiao J.-K.; Lin C.-P.; Yao M.; Huang D.-M. | Nanoscale | | 29 | |
| 2016 | Dextran-coated iron oxide nanoparticles turn protumor mesenchymal stem cells (MSCs) into antitumor MSCs | Chung T.-H.; Hsieh C.-C.; Hsiao J.-K.; SZU-CHUN HSU ; Yao M.; Huang D.-M. | RSC Advances | | 10 | |
| 2010 | Distinct clinical and biologic characteristics in adult acute myeloid leukemia bearing the isocitrate dehydrogenase 1 mutation | Chou W.-C.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; SZU-CHUN HSU ; Chen Y.-C.; Huang Y.-N.; Chang Y.-.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. | Blood | | 167 | |
| 2010 | Distinct clinical and biological features of de novo acute myeloid leukemia with additional sex comb-like 1 (ASXL1) mutations | Chou W.-C.; Huang H.-H.; Hou H.-A.; Chen C.-Y.; Tang J.-L.; Yao M.; Tsay W.; Ko B.-S.; Wu S.-J.; Huang S.-Y.; SZU-CHUN HSU ; Chen Y.-C.; Huang Y.-N.; Chang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tseng M.-H.; Huang C.-F.; Tien H.-F. | Blood | | 143 | |
| 2021 | Distinct clinico-biological features in AML patients with low allelic ratio FLT3-ITD: role of allogeneic stem cell transplantation in first remission | TIEN FENG-MING; Tsai, Cheng-Hong; Huang, Sheng-Chuan; LIU JIA-HAU; Chen, Chien-Yuan; Kuo, Yuan-Yeh; Chuang, Yi-Kuang; Tseng, Mei-Hsuan; Peng, Yen-Ling; Liu, Ming-Chih; Liu, Chia-Wen; Liao, Xiu-Wen; Lin, Liang-In; Wu, Yu-Sin; Hou, Mei-Fang; Wu, Shang-Ju; SZU-CHUN HSU ; Ko, Bor-Sheng; Chou, Wen-Chien; MING YAO; Hou, Hsin-An; Tang, Jih-Luh; Tien, Hwei-Fang | Bone marrow transplantation | 0 | 0 | |
| 2016 | Distinct mutation profile and prognostic relevance in patients with hypoplastic myelodysplastic syndromes (h-MDS) | Yao C.-Y.; Hou H.-A.; Lin T.-Y.; Lin C.-C.; Chou W.-C.; Tseng M.-H.; Chiang Y.-C.; Liu M.-C.; Liu C.-W.; Kuo Y.-Y.; Wu S.-J.; Liao X.-W.; Lin C.-T.; Ko B.-S.; Chen C.-Y.; SZU-CHUN HSU ; Li C.-C.; Huang S.-Y.; Yao M.; Tang J.-L.; Tsay W.; Liu C.-Y.; Tien H.-F. | Oncotarget | | 14 | |
| 2012 | DNMT3A mutations in acute myeloid leukemia: Stability during disease evolution and clinical implications | Hou H.-A.; Kuo Y.-Y.; Liu C.-Y.; Chou W.-C.; Lee M.C.; Chen C.-Y.; Lin L.-I.; Tseng M.-H.; Huang C.-F.; Chiang Y.-C.; Lee F.-Y.; Liu M.-C.; Liu C.-W.; Tang J.-L.; Yao M.; Huang S.-Y.; Ko B.-S.; SZU-CHUN HSU ; Wu S.-J.; Tsay W.; Chen Y.-C.; Tien H.-F. | Blood | | 170 | |
